Company profile

Apollon

Apollon develops noninvasive continuous glucose monitoring systems.

Location: Cambridge, Massachusetts, United States, North America
Website: apollon.bio

Latest known funding

Series A round

Capital: $3.7M
Announced: Sep 22, 2026

Lead investors

Participating investors

Daewoong Future Science and Technology Holdings Korea Credit Guarantee Fund Naver